Fetal dose estimates for18F-fluoro-l-thymidine using a pregnant monkey model

Journal of Nuclear Medicine

Volumn 51, Issue 2, 2010, Pages 288-292

  Bartlett, Rachel M ^a   Nickles, Robert J ^a   Barnhart, Todd E ^a   Christian, Bradley T ^a   Holden, James E ^a   DeJesus, Onofre T ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

18F fluoro l thymidine (FLT); Dosimetry; Fetus

Indexed keywords

FLUORO THYMIDINE F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; FETUS LIVER; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION DOSE; RHESUS MONKEY;

ADULT; ANIMALS; DIDEOXYNUCLEOSIDES; FEMALE; FETUS; HUMANS; MODELS, ANIMAL; POSITRON-EMISSION TOMOGRAPHY; PREGNANCY; RADIATION DOSAGE; RADIOPHARMACEUTICALS; RISK ASSESSMENT; SPECIES SPECIFICITY; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED;

EID: 75749087646     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.068734     Document Type: Article

References (35)

1. Shi CY, Xu XG, Stabin MG. SAF values for internal photon emitters calculated for the RPI-P pregnant-female models using Monte Carlo methods. Med Phys. 2008;35:3215-3224.
2. Vicini P, Brill AB, Stabin MG, Rescigno A. Kinetic modeling in support of radionuclide dose assessment. Semin Nucl Med. 2008;38:335-346.
3. 18F-FDG. J Nucl Med. 2004;45:634-635.
4. Mankoff DA, Shields AF, Krohn KA. PET imaging of cellular proliferation. Radiol Clin North Am. 2005;43:153-167.
5. Bading JR, Shields AF. Imaging of cell proliferation: status and prospects. J Nucl Med. 2008;49(suppl 2):64S-80S.
6. Sherley JL, Kelly TJ. Regulation of human thymidine kinase during the cell cycle. J Biol Chem. 1988;263:8350-8358.
7. 18F]FLT. Nucl Med Biol. 2002;29:263-273.
8. Digiacomo RF, Shaughnessy PW, Tomlin SL. Fetal-placental weight relationships in the rhesus (Macaca mulatta). Biol Reprod. 1978;18:749-753.
9. 32P]dTTP of the enzyme from spleen, liver, heart and brain. Eur J Biochem. 1992;206:485-490.
10. 18F]FLT) and simple method for metabolite analysis in plasma. Radiochimica Acta. 2006;94:447-451.
11. 18F]3′-deoxy-3′-fluorothymidine metabolism and retention. Eur J Nucl Med Mol Imaging. 2005;32:1269-1275.
12. 11C-PBR28: a PET radioligand to image inflammation. J Nucl Med. 2007;48:2072-2079.
13. 131I-19-iodocholesterol. J Nucl Med. 1973;14:713-717.
14. Newell-Morris L, Fahrenbruch C. Practical and evolutionary considerations for use of the nonhuman primate model in prenatal research. In: Watts E, ed. Nonhuman Primate Models for Human Growth and Development. A.R. Liss; 1985:9-40.
15. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027.
16. 59Fe kinetic studies at Vanderbilt University in the 1940's. Health Phys. 1997;72:701-707.
17. Gimondo P, Mirk P, La Bella A, Messina G, Pizzi C. Sonographic estimation of fetal liver weight: an additional biometric parameter for assessment of fetal growth. J Ultrasound Med. 1995;14:327-333.
18. Millard RK, Saunders M, Palmer AM, Preece AW. Approximate distribution of dose among foetal organs for radioiodine uptake via placenta transfer. Phys Med Biol. 2001;46:2773-2783.
19. 18F-fluorothymidine radiation dosimetry in human PET imaging studies. J Nucl Med. 2003;44:1482-1488.
20. Steenvoorde P, Pauwels EK, Harding LK, Bourguignon M, Mariere B, Broerse JJ. Diagnostic nuclear medicine and risk for the fetus. Eur J Nucl Med. 1998; 25:193-199.
21. Russell JR, Stabin MG, Sparks RB. Placental transfer of radiopharmaceuticals and dosimetry in pregnancy. Health Phys. 1997;73:747-755.
22. Lindberg BS, Hartvig P, Lilja A, et al. Positron-emission tomography: a new approach to feto-maternal pharmacokinetics. NIDA Res Monogr. 1985;60:88-97.
23. Hartvig P, Lindberg BS, Lilja A, Lundqvist H, Langstrom B, Rane A. Positron emission tomography in studies on fetomaternal disposition of opioids. Dev Pharmacol Ther. 1989;12:74-80.
24. Berglund L, Andersson J, Lilja A, et al. Amino acid transport across the placenta measured by positron emission tomography and analyzed by compartment modelling. J Perinat Med. 1990;18:89-100.
25. Berglund L, Lilja A, Andersson J, et al. Maternal blood volume in placenta of the rhesus monkey measured in vivo by positron emission tomography. Gynecol Obstet Invest. 1991;31:1-7.
26. Benveniste H, Fowler JS, Rooney WD, et al. Maternal-fetal in vivo imaging: a combined PET and MRI study. J Nucl Med. 2003;44:1522-1530.
27. 11C-cocaine uptake and kinetics measured in vivo by combined PET and MRI in pregnant nonhuman primates. J Nucl Med. 2005;46:312-320.
28. DeJesus OT, Flores LG, Converse AK, et al. Assessing environmental chemical uptake in fetal brain in utero: a preliminary PET/CT study. J Radioanal Nucl Chem. 2006;269:561-564.
29. Bartlett RM, Nickles RJ, Murali D, et al. Paraquat uptake in adult and fetal macaque brain in vivo: a PET study [abstract]. Turku PET Symposium Book of Abstracts. 2008:15. Available at: http:pet.utu.fi/files/PET2008-book-of- abstracts.pdf. Accessed November 5, 2009.
30. 18F]fluoro-2-deoxy-D-glucose in adult humans. J Nucl Med. 1991;32:707-712.
31. Thomas SR, Stabin MG, Chen CT, Samaratunga RC. MIRD pamphlet no. 14: a dynamic urinary bladder model for radiation dose calculations. J Nucl Med. 2002;33:783-802.
32. National Council on Radiation Protection and Measurements. Considerations Regarding the Unintended Radiation Exposure of the Embryo, Fetus or Nursing Child. Bethesda, MD: NCRP Publications; 1994. NCRP commentary no. 9.
33. Shields AF, Grierson JR, Dohmen BM, et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med. 1998;4:1334-1336.
34. Blackburn ST. Maternal, Fetal, & Neonatal Physiology: A Clinical Perspective. 3rd ed. St. Louis, MO: Saunders (Elsevier Health Sciences); 2007:243-244.
35. Kiserud T, Rasmussen S, Skulstad SM. Blood flow and degree of shunting through the ductus venosus in the human fetus. Am J Obstet Gynecol. 2000;182:147-153.